Viatris (VTRS) Cash & Current Investments (2019 - 2026)

Viatris' (VTRS) quarterly Cash & Current Investments came in at $1.8 billion in Q1 2026, up 138.97% year-on-year from $755.0 million in Q1 2025, and up 36.43% quarter-over-quarter from $1.3 billion in Q4 2025.

Viatris (VTRS) Cash & Current Investments (2019 - 2026) Analysis & Trends

Viatris' Cash & Current Investments history runs 8 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 138.97% year-over-year to $1.8 billion in Q1 2026; TTM through Mar 2026 was $1.8 billion, a 138.97% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 79.65% from the prior year.
  • Cash & Current Investments advanced to $1.8 billion in Q1 2026 per VTRS's latest filing, from $1.3 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $1.9 billion in Q3 2024 and bottomed at $506.6 million in Q1 2023.
  • The 5-year median for Cash & Current Investments is $917.2 million (2024), against an average of $984.3 million.
  • Across the five-year window, Cash & Current Investments slumped 48.09% in 2025 and jumped 138.97% in 2026, its largest moves.
  • Year by year, Cash & Current Investments stood at $1.3 billion in 2022, then declined by 21.43% to $991.9 million in 2023, then retreated by 25.79% to $736.1 million in 2024, then jumped by 79.65% to $1.3 billion in 2025, then soared by 36.43% to $1.8 billion in 2026.
  • Per Business Quant, the three latest VTRS Cash & Current Investments figures stand at $1.8 billion (Q1 2026), $1.3 billion (Q4 2025), and $975.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.06 Bn 87.19 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.81 Bn 32.07 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.50 Bn 30.56 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.51 Bn 23.45 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 23.19 Bn 21.04 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 21.76 Bn 21.76 Bn - -
7 Viatris 20.28 Bn 18.47 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.72 Bn 16.40 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.56 Bn 12.13 Bn 785.00 Mn 428.00 Mn
10 Vireo Growth 10.52 Bn 10.37 Bn 59.30 Mn 153.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.80 Bn
Dec 31, 2025 1.32 Bn
Sep 30, 2025 975.30 Mn
Jun 30, 2025 566.40 Mn
Mar 31, 2025 755.00 Mn
Dec 31, 2024 736.10 Mn
Sep 30, 2024 1.88 Bn
Jun 30, 2024 917.20 Mn
Mar 31, 2024 1.01 Bn
Dec 31, 2023 991.90 Mn
Sep 30, 2023 1.31 Bn
Jun 30, 2023 629.20 Mn
Mar 31, 2023 506.60 Mn
Dec 31, 2022 1.26 Bn
Sep 30, 2022 646.70 Mn
Jun 30, 2022 664.70 Mn
Mar 31, 2022 752.40 Mn
Dec 31, 2021 706.20 Mn
Sep 30, 2021 756.60 Mn
Jun 30, 2021 673.90 Mn